Patents Assigned to Foundation
  • Publication number: 20100249400
    Abstract: Disclosed is a compound represented by the formula (I) below as a dihydronaphthalene compound having a chemical structure which is excellent in production efficiency when compared with lasofoxifene and nafoxidine. This compound is useful as a proteasome inhibitor and/or an antitumor agent.
    Type: Application
    Filed: September 11, 2008
    Publication date: September 30, 2010
    Applicant: Tokyo University of Science Educational Foundation Administrative Organization
    Inventor: Isamu Shiina
  • Publication number: 20100243479
    Abstract: This invention relates to a sensor for detecting a stem cell differentiation, including (a) an electrode; and (b) a substrate of an alkaline phosphatase. The phosphorylation or dephosphorylation of the substrate for an alkaline phosphatase as a stem cell undifferentiation marker which dephosphorylates its substrate may be measured using an electrical signal in the present sensor. Therefore, the sensor of the present invention enables to electrically detect a stem cell status in a high-throughput manner and to determine the stem cell differentiation.
    Type: Application
    Filed: October 14, 2009
    Publication date: September 30, 2010
    Applicant: Industry-University Cooperation Foundation Sogang University
    Inventors: Jeong-Woo Choi, Cheol-Heon Yea
  • Patent number: 7803921
    Abstract: Isolated sulfotransferase nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as sulfotransferase allozymes. Methods for determining if a mammal is predisposed to cancer also are described.
    Type: Grant
    Filed: September 25, 2007
    Date of Patent: September 28, 2010
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Araba A. Adjei, Eric D. Wieben, Richard M. Weinshilboum, Bianca A. Thomae
  • Patent number: 7804455
    Abstract: Provided are an antenna apparatus for linearly polarized diversity antennas in a radio frequency identification (RFID) reader, and a method of controlling the antenna apparatus. The antenna apparatus includes: a plurality of linearly polarized diversity antennas disposed to have different directions to one another; a switching unit connecting the linearly polarized diversity antennas to the RFID reader; and a controller controlling the switching unit to selectively activate the linearly polarized diversity antennas.
    Type: Grant
    Filed: July 24, 2007
    Date of Patent: September 28, 2010
    Assignees: Electronics and Telecommunications Reseach Institute, Chungbuk National University Industry-Academic Cooperation Foundation
    Inventors: Jong Moon Lee, Nae-Soo Kim, Cheol Sig Pyo, Ik Guen Choi
  • Patent number: 7803752
    Abstract: The present invention relates to methods of inducing neuronal production in the brain, recruiting neurons to the brain, and treating a neurodegenerative condition by providing a nucleic acid construct encoding a neurotrophic factor, and injecting the nucleic acid construct intraventricularly into a subject's brain.
    Type: Grant
    Filed: March 29, 2006
    Date of Patent: September 28, 2010
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Steven A. Goldman, Abdellatif Benraiss
  • Patent number: 7803912
    Abstract: The disclosure relates to recombinant adult human apohemoglobin (apo-rHb) in which the stability has been increased by replacement of an amino acid with a counterpart from another organism, such as a deep sea diving mammal. This mutated apo-rHb may be more stable and/or give higher production yields than unmutated adult human apo-rHb. The mutated apo-rHb may be produced in microorganisms, such as E. coli or yeast cells, or animal erythroid cells. Some apo-rHb of the present disclosure may be used as part of a blood substitute.
    Type: Grant
    Filed: March 14, 2007
    Date of Patent: September 28, 2010
    Assignees: William Marsh Rice University, Wisconsin Alumni Research Foundation
    Inventors: John S. Olson, George N. Phillips, Jr.
  • Patent number: 7803364
    Abstract: An isolated multipotent neural stem cells has a phenotype identified by expression of the protein ?-tubulin IV and Olig2 and the absence of the proteins NG2, PLP, and GFAP.
    Type: Grant
    Filed: November 17, 2006
    Date of Patent: September 28, 2010
    Assignee: The Cleveland Clinic Foundation
    Inventors: Bruce Trapp, Robert Miller
  • Patent number: 7804928
    Abstract: The present invention relates to targets, systems and methods for the cyclotron production of 124I from aluminum telluride (Al2Te3) targets. The systems and methods utilize low energy proton cyclotrons to produce 124I by the 124Te(p,n) reaction from enriched Al2Te3 glassy melts. The 124I is recovered in high yield from the glassy melt by adapted methods of common thermal distillation techniques.
    Type: Grant
    Filed: December 11, 2008
    Date of Patent: September 28, 2010
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Jonathon Andrew Nye, Robert Jerome Nickles
  • Patent number: 7803984
    Abstract: The present invention relates to compositions and methods for controlling nematode infestation of plants. In particular, the present invention provides vectors comprising sequences designed to control nematodes by RNA interference (RNAi) and transgenic plants transformed with such vectors.
    Type: Grant
    Filed: July 9, 2003
    Date of Patent: September 28, 2010
    Assignee: Kansas State University Research Foundation
    Inventors: Harold N. Trick, Judith L. Roe, Timothy C. Todd, Michael A. Herman
  • Patent number: 7803707
    Abstract: The present invention provides metal silicide nanowires, including metallic, semiconducting, and ferromagnetic semiconducting transition metal silicide nanowires. The nanowires are grown using either chemical vapor deposition (CVD) or chemical vapor transport (CVT) on silicon substrates covered with a thin silicon oxide film, the oxide film desirably having a thickness of no greater than about 5 nm and, desirably, no more than about 2 nm (e.g., about 1-2 nm). The metal silicide nanowires and heterostructures made from the nanowires are well-suited for use in CMOS compatible wire-like electronic, photonic, and spintronic devices.
    Type: Grant
    Filed: August 17, 2006
    Date of Patent: September 28, 2010
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Song Jin, Andrew L. Schmitt, Yipu Song
  • Patent number: 7804518
    Abstract: A method for enhancing underwater imaging affected by image degradation effects, the method comprising: acquiring at least one image of an underwater scene using an imaging device; determining information regarding distances of parts of the scene relative to the imaging device; and reconstructing an image of the underwater scene using a physics-based mathematical model, compensating image characteristics influenced by distance-dependent underwater degradation effects including veiling light, using the information on the distances of parts of the scene from the imaging device, and compensating distance-dependent underwater degradation effects relating to the distance of illumination sources from the scene.
    Type: Grant
    Filed: February 13, 2005
    Date of Patent: September 28, 2010
    Assignee: Technion Research and Development Foundation Ltd.
    Inventors: Yoav Schechner, Nir Karpel
  • Patent number: 7805176
    Abstract: Method and system that provides, among other things, the capability for using hyperpolarized xenon-129 as a probe to non-invasively and non-destructively characterize important properties of certain structures or materials into which hyperpolarized xenon-129 can be introduced and wherein the xenon exists in two or more chemically-shifted states that are in exchange High-resolution MR images can be generated in a fraction of a second wherein the associated signal intensities reflect material properties that characterize the gas exchange among the different states. For example, in the human or animal lung, the system and related method can exploit the differences in gas-exchange characteristics between healthy and diseased lung tissue to generate high-resolution, high signal-to-noise cross-sectional MR images that permit non-invasive regional detection of variations in lung tissue structure with a combination of spatial and temporal resolution that is unmatched by any current imaging modality.
    Type: Grant
    Filed: March 9, 2005
    Date of Patent: September 28, 2010
    Assignee: University of Virginia Patent Foundation
    Inventors: Kai Ruppert, John P. Mugler, III, James R. Brookeman
  • Patent number: 7805012
    Abstract: Methods and systems are disclosed for signal processing. A method includes receiving a plurality of digitized coefficients determining a best-fit distribution of a general family of distributions for the plurality of digitized coefficients, and providing a characterization of the digitized coefficients based upon the determined best-fit distribution. The system includes a memory for storing computer program instructions and a processor in communication with the memory. The processor is operable to execute the computer program instructions to receive a plurality of digitized coefficients, determine a best-fit distribution of a general family of distributions for the plurality of digitized coefficients, and provide a characterization of the digitized coefficients based upon the determined best-fit distribution.
    Type: Grant
    Filed: February 21, 2007
    Date of Patent: September 28, 2010
    Assignee: Florida State University Research Foundation
    Inventor: Kai-Sheng Song
  • Patent number: 7803568
    Abstract: The present invention is directed to methods and products related to carbodithioate ligands bonded to surfaces. The invention is further directed to molecular and biomolecular sensing methods based on analyte recognition by carbodithioate ligands bonded to surfaces.
    Type: Grant
    Filed: April 20, 2006
    Date of Patent: September 28, 2010
    Assignee: Purdue Research Foundation
    Inventors: Alexander Wei, Yan Zhao
  • Patent number: 7803789
    Abstract: Compounds of formula IA or IB are provided where X1, X2 and X3 are independently selected from H or hydroxy protecting groups and R1 is selected from straight or branched chain alkyl groups having from 1 to 8 carbon atoms; straight or branched chain alkenyl groups having from 2 to 8 carbon atoms; straight or branched chain hydroxy-substituted alkyl groups having from 1 to 8 carbon atoms; straight and branched chain hydroxy-substituted alkenyl groups having from 2 to 8 carbon atoms. Such compounds are used in preparing pharmaceutical compositions and are useful in treating a variety of biological conditions.
    Type: Grant
    Filed: January 30, 2007
    Date of Patent: September 28, 2010
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Hector F. Deluca, Grazia Chiellini, Pawel Grzywacz, Lori A. Plum, Margaret Clagett-Dame
  • Patent number: 7802970
    Abstract: A micropump including one or more microchannels for receiving a fluid and a plurality of electrodes arranged on a diaphragm and energized in a manner to provide an enhanced electrohydrodynamic flow of fluid through the one or more microchannels. The micropump may be used for pumping a working fluid for removing heat from a heat-generating electronic component or for delivery of a drug, medicine, or other treatment agent as or in a fluid to a patient.
    Type: Grant
    Filed: May 30, 2006
    Date of Patent: September 28, 2010
    Assignee: Purdue Research Foundation
    Inventors: Vishal Singhal, Suresh V. Garimella
  • Patent number: 7805183
    Abstract: The present invention provides methods and systems for evaluating biological materials for the diagnosis of disease, such as gland abnormalities, and the cancerous and precancerous conditions. Nonlinear optical microscopy techniques, such as MP microscopy and harmonic generation microscopy, are used to generate high resolution, three dimensional images of a test tissue, such as a biopsy tissue sample and tissue in whole organisms, that are analyzed, optionally in combination, to detect, identify and characterize tumor-associated collagen signatures. The presence, abundance and extent of histological features and structural motifs comprising tumor-associated collagen signatures may be directly and accurately correlated with the onset and progression of cancer, such as breast cancer. The present methods are capable of providing an accurate and selective diagnosis of cancer, and provide diagnostic information complementary to conventional diagnostic methods.
    Type: Grant
    Filed: June 21, 2007
    Date of Patent: September 28, 2010
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Patricia Jo Keely, Paolo P. Provenzano, John Graham White, Kevin William Eliceiri
  • Patent number: 7803970
    Abstract: This invention provides a class of androgen receptor targeting agents (ARTA). The agents define a new subclass of compounds, which are selective androgen receptor modulators (SARM). Several of the SARM compounds have been found to have an unexpected androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. Other SARM compounds have been found to have an unexpected antiandrogenic activity of a nonsteroidal ligand for the androgen receptor.
    Type: Grant
    Filed: June 7, 2004
    Date of Patent: September 28, 2010
    Assignee: University of Tennessee Research Foundation
    Inventors: James T. Dalton, Duane D. Miller, Mitchell S. Steiner, Karen A. Veverka, Dong Jin Hwang, Jiyun Chen
  • Patent number: 7804299
    Abstract: A preparatory pulse sequence is applied prior to an imaging pulse sequence during a diffusion-weighted MRI scan. The preparatory pulse sequence diffusion weights the longitudinal magnetization using a gradient waveform that is first moment nulled to reduce image artifacts caused by patient motion.
    Type: Grant
    Filed: May 4, 2007
    Date of Patent: September 28, 2010
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Scott B. Reeder, Reed Busse, Jean H. Brittain
  • Patent number: PP21317
    Abstract: A new and distinct variety of strawberry (Fragaria×ananassa), which originated from seed produced by a hand-pollinated cross between FL 96-114 and FL 95-200. The new strawberry, named ‘Florida Elyana’, is distinguished by production of large, firm, exceptionally flavored fruit and resistance to crown and fruit rots when grown in west central Florida or other areas that have a subtropical climate similar to that of west central Florida.
    Type: Grant
    Filed: June 20, 2008
    Date of Patent: September 28, 2010
    Assignee: Florida Foundation Seed Producers, Inc.
    Inventor: Craig Chandler